Muscular dystrophy treatment with gene-targeting therapy

Muscular dystrophy refers to a genetic disease. Such disorders cause muscle weakness and loss of muscle tissue. Since it's related to genes, a gene-targeting therapy has been developed. This method zeroes in on the disease-causing genes, altering them so they can't worsen the disease. One example of this treatment is used for Duchenne muscular dystrophy (DMD) when doctors create a smaller, modified version of the problem gene. It is transported to the muscle cells in the body using a viral vector, like a delivery truck. It's a one-time treatment that can slow the disease's progression and improve muscle function. The detailed diagnosis process is performed first. Doctors examine the patient's health history, including past illnesses and family history. They review the health records and perform a thorough physical examination. Doctors conduct several lab tests to evaluate overall health and look for inflammation and specific indicators of muscle damage. They also perform neurological exams to assess muscle strength, balance, and reflexes. Measuring muscle electrical activity can help tell muscular dystrophy apart from other diseases. As of now, there's no complete cure for muscular dystrophy. But, treatments like gene therapy are promising. They can help manage the symptoms of the disease and allow patients to maintain their independence.